National and Kapodistrian University of Athens
Βιοχημικοί δείκτες καρδιακής λειτουργίας σε μακροσωμικά έμβρυα-νεογνά
Abstract
dc:descriptionThis thesis consists of two parts, the GENERAL and the SPECIFIC I. FETAL GROWTH. The 3 phases of fetal growth, which takes place during gestation, are analyzed as well as the factors affecting fetal development. A separation is made between physiological and abnormal fetal growth and the method for determining gestational age, based not only on the ultrasound assessment but on other factors as well, is described. The criteria, based on which the detection and the separation to LGA, AGA, SGA, IUGR fetuses is made, are presented and finally the curves in which each fetal group is classified, are analyzed. II. LARGE FOR GESTATIONAL AGE NEONATES (LGA). The term LGA is defined and the causes leading to birth of macrosomic fetuses are presented. A detailed report is delivered on Gestational Diabetes Mellitus and on infants born to diabetic mothers. The short- and long-term complications of fetal macrosomia are examined, the most significant ones being perinatal injuries, metabolic and respiratory problems, congenital malformations and cardiovascular diseases. III. CARDIOVASCULAR FETAL DISEASES AND ULTRASOUND STUDIES. In this chapter, the causative factors of congenital heart diseases are reported and the physiology of fetal heart function together with the morphological characteristics of the heart cavities, set out by ultrasound studies, are documented. The most frequent fetal congenital heart diseases are described, including the risk factors which are both environmental and genetic. Great importance is attributed to the relationship between gestational diabetes mellitus and hypertrophic cardiomyopathy, characterizing fetal-neonatal macrosomia.IV. BIOMARKERS. The definition of a biomarker is included and its required characteristics in order to achieve wide sensitivity and specificity and constitute an ideal biomarker are presented. The use of biomarkers in the neonatal and perinatal period to date, a well as the discovery of novel biomarkers which, in the future, will be useful for the prognosis and monitoring of pathological conditions are discussed. The Special part includes the following chapters: I. Hypothesis and aim of studiesThis study is based on the hypothesis that concentrations of CT-1 (as well as concentrations of other biomarkers such as sCD36, PTX-3 and Titin which circulate in the blood and are traced in plasma) may be higher in macrosomic fetuses, reflecting a probable predisposition for cardiovascular diseases, such as hypertrophic cardiomyopathy, hypertension, heart failure, valvular heart diseases, metabolic syndrome and chronic renal failure. Therefore, this study aims to detect and investigate changes in the circulating levels of the aforementioned biomarkers during birth in the umbilical cord blood of LGA fetuses, as compared to AGA ones. Finally, the above circulating levels of biomarkers will be associated with various perinatal parameters (maternal age, parity, gestational age, mode of delivery, birth weight, customized centile, fetal gender). II. The Thesis material and the methods for determining the biochemical markers IV. MATERIAL. We collected 80 blood samples from the doubly-clamped umbilical cord at birth (reflecting the fetal state). Forty samples derived from uncomplicated AGA gestations whilst the rest 40 came from LGA pregnancies. The causes for the LGA pregnancies were maternal diabetes in 8 cases, maternal obesity in 11 cases, excessive gestational weight gain in 7 cases, while in the rest 14 ones no specific pathology was recorded. All pregnancies were singletons. As large for gestational age (LGA) infants were considered those with a birth weight above 4000gr and above the 90th customized centile, which has been calculated for each neonate by using the computer-generated programme GROW (Gestation Related Optimal Weight), as documented by Gardosi et al. The individualized centile was calculated, taking into consideration all significant determinants of fetal growth, such as gestational age, gender, maternal height and booking weight, ethnic group and parity. The determination of the biomarkers was performed by sensitive enzyme-linked immunosorbent assays (ELISA). Parametric and non parametric methods were applied in the statistical analysis, based on the normality or not of the data distribution and selectively a multiple factor analysis. III. Results CARDIOTROPHIN-1 (CT-1) •In the final linear regression model, the effect of group (AGA or LGA) on CT-1 concentrations was significant. Therefore, cord blood CT-1 concentrations were significantly higher in LGA, compared to the AGA group. •The sub-group analysis in the LGA group indicated increased CT-1 umbilical cord blood levels only in the complicated by gestational diabetes mellitus cases. •In the LGA group, the effect of delivery mode on umbilical cord CT-1 concentrations was significant. •The CT-1 concentrations were significantly lower in neonates born by caesarian section, compared to the ones born by vaginal delivery.PENTRAXIN-3 (PTX-3). •PTX-3 umbilical cord blood concentrations were similar in LGA and AGA neonates. •However, in the macrosomic group, PTX-3 levels positively correlated with birth weight. •Furthermore, cord blood PTX-3 levels positively correlated with gestational age. •In the macrosomic group cord blood PTX-3 concentrations were positively associated with maternal obesity. •A positive correlation was recorded between PTX-3 and sCD36 concentrations. •No correlation was identified between cord blood CT-1 levels and respective PTX-3 ones.Soluble CD36 and Titin•Cord blood sCD36 concentrations were similar in LGA and AGA neonates. •In macrosomic neonates, cord blood PTX-3 concentrations positively correlated with sCD36 ones. •The effect of group on Titin concentrations was significant. •Cord blood Titin concentrations were higher in LGA, than AGA neonates. •Cord blood Titin positively correlated with CT-1 and PTX-3.Summing up our results, we conclude the following: 1. The increased CT-1 levels in LGA fetuses/neonates born to diabetic mothers provide serologically-based prospective evidence of abnormal CT-1 expression in response to maternal diabetes already at birth and probably suggest a predisposition for later development of cardiovascular disease. On the other hand, other common causes of fetal macrosomia do not seem to affect cardiotrophin-1 levels in cord blood. The statistically higher CT-1 concentrations in fetuses/neonates delivered vaginally versus those delivered by elective caesarean section could also be attributed to the hypoxic and inflammatory conditions, associated with vaginal delivery. 2. Cord blood PTX-3 is probably not affected by excessive fetal growth. Yet, the positive correlation between cord blood PTX-3 and birth weight in the macrosomic group may indicate a predisposition to later cardiovascular pathology in the severe LGA cases. The positive correlation of PTX-3 with gestational age can be attributed to the increased placental expression of the protein as pregnancy progresses. 3. The higher cord blood Titin concentrations in LGA pregnancies possibly represent a candidate molecular mechanism, underlying the association between fetal macrosomia and cardiomyocyte/diastolic dysfunction, associated with later cardiovascular disease. The positive correlation of Titin with the respective concentrations of CT-1 and PTX-3, probably underlines its rapidly evolving role in cardiac physiology and cardiomyopathy. It is notable that no differentiation was found in the expression of Titin in various subgroups of LGA, probably implying that this molecule is less specific as a prognostic marker, associated with gestational diabetes mellitus.4. Cord blood sCD36 concentrations do not seem to be affected by fetal macrosomia. Nonetheless, the positive correlation between cord blood PTX-3 and respective sCD36 concentrations in the macrosomic group might indicate an inflammatory pathway, linking extreme fetal growth with the predisposition to metabolic syndrome and cardiovascular pathology later in life. The determination of various cardiac biomarkers, such as CT-1 and probably Titin in umbilical cord blood may have an early prognostic value for subsequent development of cardiovascular disease in fetal macrosomia.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Germanou, Kleopatra
- Γερμανού, Κλεοπάτρα
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48051